PBS show on Rachel Carson and Silent Spring would include "interviews with foes and friends." The interviews with "foes" were with only one person: myself. The only other opponent was Professor Robert White-Stevens of Rutgers University, who died several years ago and thus, for obvious reasons, was not interviewed. Instead, two or three selected film clips were shown, to represent him as a spokesman for the pesticide industry. Several "friends" came on camera for a total of about 30 times, plus
Topics that were not mentioned were the use of DDT by the World Health Organization, and the fact that it saved millions of lives from malaria. I had discussed such matters when I was videotaped, but these parts of the tape were not used.
THOMAS H. JUKES
Department of Integrative Biology
University of California
Berkeley
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
